ライフサイエンスコーパス: urinary albumin

1 term graft loss independent of histology and urinary albumin.

2 nt the development of excessive excretion of urinary albumin.

3 f the controls and was detected earlier than urinary albumin.

4 n of CKD than the current clinical standard, urinary albumin.

5 uted to impaired kidney function (eGFR: 30%; urinary albumin: 5%) but not to inflammation.

6 Urinary albumin and creatinine concentrations were deter

7 C was measured by using a nephelometer, and urinary albumin and creatinine were measured from a spot

8 Urinary albumin and estimated glomerular filtration rate

9 rs receptor-mediated endocytosis, increasing urinary albumin and glucose excretion and impairing weig

10 Urinary albumin and N-acetyl-beta-D-glucosaminidase was

11 es and contributing to enhanced excretion of urinary albumin and recruitment/activation of inflammato

12 ater than that with eplerenone, reduction in urinary albumin, and renal protection.

13 d pressure, kidney weight/body weight ratio, urinary albumin, and urinary thiobarbituric acid-reactin

14 clude the albumin:creatinine ratio (ACR) and urinary albumin concentration (UAC) obtained from a sing

15 hin-pair coefficients of variation (CVs) for urinary albumin concentration and other urinary variable

16 After exclusion of urinary albumin concentration pairs with values below th

17 For urinary albumin concentration, exclusion of one mislabel

18 e, diabetes, serum creatinine concentration, urinary albumin concentration, previous cardiovascular e

19 ab38 knockout and control rats showed higher urinary albumin concentrations and reduced amounts of me

20 The relationship between CVD and urinary albumin content (even within the normal range) i

21 blood glucose, post prandial blood glucose, urinary albumin creatine ratio, erythrocyte sedimentatio

22 protein-cholesterol (LDL-C) (p = 0.0009) and urinary albumin creatinine ratio (p < 0.0001) improved.

23 cal Evaluation) trial in patients with T2DM, urinary albumin-creatinine ratio >300 mg/g, and estimate

24 HbA1c levels, urinary albumin-creatinine ratio (p = 0.041), average ce

25 interval, 1.21-1.55; P<0.001) and increased urinary albumin-creatinine ratio (P<0.001) were identifi

26 If the urinary albumin-creatinine ratio (UACR) >= 30 mg/g, it w

27 icipants with type 2 diabetes mellitus and a urinary albumin-creatinine ratio (UACR) >=150 mg/g (17.0

28 mg/dl, eGFR >=25 ml/min per 1.73 m(2), and a urinary albumin-creatinine ratio (UACR) 30-5000 mg/g to

29 Also, urinary albumin-creatinine ratio (UACR) showed no signif

30 sortium provided GWAS summary data for eGFR, urinary albumin-creatinine ratio (UACR), BUN, and serum

31 th CKD (eGFR >=20 ml/min per 1.73 m(2) and a urinary albumin-creatinine ratio of 150-5000 mg/g) were

32 73 m2, and microalbuminuria was defined as a urinary albumin-creatinine ratio of 30 to 300 mg/g.

33 x, estimated glomerular filtration rate, and urinary albumin-creatinine ratio up to 10 y posttranspla

34 The highest sex-specific quartile of urinary albumin-creatinine ratio was associated with a s

35 l indices of central adiposity and increased urinary albumin-creatinine ratio, which enable further r

36 ) (1.1, 1.4) versus 1.2 (1.0, 1.4)), and AUC urinary albumin-creatinine ratios 69 (40, 112) versus 58

37 oglobin A1c >=6.5% or self-report and CKD by urinary albumin/creatinine >=30 mg/g or glomerular filtr

38 GFR 20-44 or 45-59 ml/min per 1.73 m(2) with urinary albumin/creatinine (ACR) >=50 mg/g and serum bic

39 h sCrry expression was maximally stimulated (urinary albumin/creatinine = 12.4 +/- 4.3 and 36.9 +/- 7

40 Kidney disease, defined as urinary albumin/creatinine ratio >/=30 mg/g and/or estim

41 e, known diabetes duration, waist/hip ratio, urinary albumin/creatinine ratio (ACR) and fasting C-pep

42 beta=-0.21 per 1-SD increment; P=0.005), and urinary albumin/creatinine ratio (beta=-0.15 per 1-SD in

43 o, 1.39 per 1-SD increment; P=0.002) and log-urinary albumin/creatinine ratio (hazard ratio, 1.31 per

44 2.3%) with moderately increased albuminuria (urinary albumin/creatinine ratio [UACR] 30-300 mg/g) and

45 Urinary albumin/creatinine ratio also was significantly

46 smoking, type 2 diabetes, higher body size, urinary albumin/creatinine ratio of >=3 mg/mmol, and hig

47 , and endothelial function (homocysteine and urinary albumin/creatinine ratio) measured at the sixth

48 Further adjustment for serum cystatin C, urinary albumin/creatinine ratio, and arterial elasticit

49 ce exhibited higher systolic blood pressure, urinary albumin/creatinine ratio, RPTC apoptosis and uri

50 elevated systolic blood pressure, increased urinary albumin/creatinine ratio, tubulo-interstitial fi

51 sed mice had chronic renal injury, increased urinary albumin/creatinine ratios, and increased tissue

52 pulse pressure, serum fibrinogen levels and urinary albumin/creatinine ratios, and with stepwise inc

53 ultrastructural renal lesions, and measured urinary albumin/creatinine ratios, tissue oxidative stre

54 enalapril attenuated CS-induced increases in urinary albumin/creatinine ratios, tissue oxidative stre

55 Impaired renal function was determined via urinary albumin/creatinine-ratio (uACR).

56 Microalbuminuria was defined as urinary albumin: creatinine ratio between 30-300 mg/g.

57 Epidemiology Collaboration equation) and/or urinary albumin:creatinine ratio >/=30 mg/g.

58 in(-1).1.73 m(-2) and 19.0% had albuminuria (urinary albumin:creatinine ratio >=30 mg/g).

59 The urinary albumin:creatinine ratio (ACR) was measured usin

60 ciation between treatment effects on 6-month urinary albumin:creatinine ratio (UACR) change and the e

61 ed glomerular filtration rate (eGFR) and the urinary albumin:creatinine ratio (uACR) were measured at

62 ar pattern was observed when we adjusted for urinary albumin:creatinine ratio in place of serum creat

63 ney disease and no history of gout who had a urinary albumin:creatinine ratio of 265 or higher (with

64 Albuminuria was defined by the urinary albumin:creatinine ratio.

65 hy Dietary Pattern was associated with lower urinary albumin:creatinine ratios, common carotid intima

66 Lorcaserin improved both eGFR and urinary albumin:creatinune ratio within the first year a

67 ulated the contribution of RBP4, prealbumin, urinary albumin, eGFR, and CRP to these associations as

68 s included progression to overt proteinuria (urinary albumin excretion > or = 300 mg/d) in half of th

69 ants had albuminuria, which was defined as a urinary albumin excretion >/=30 mg/24 h.

70 d to a normoalbuminuric or macroalbuminuric (urinary albumin excretion <30 mg/24 hours and >300 mg/24

71 ient sFlt-1 mice also showed markedly higher urinary albumin excretion (467+/-74 versus 174+/-23 mug/

72 o -0.4; P=0.003) but positively with 24-hour urinary albumin excretion (beta=0.11; 95% CI, 0.01 to 0.

73 nuria, indicated by repeated measurements of urinary albumin excretion (estimated on the basis of alb

74 btained and are reliable indices of elevated urinary albumin excretion (microalbuminuria) in IDDM.

75 ase-line blood pressure predicted increasing urinary albumin excretion (P=0.006), and higher base-lin

76 We examined the association of urinary albumin excretion (spot urine albumin indexed to

77 The prevalence of elevated urinary albumin excretion (UAE) (albumin-to-creatinine r

78 An F(1) hybrid of S and SHR showed a low urinary albumin excretion (UAE) and low urinary protein

79 Urinary albumin excretion (UAE) increased significantly

80 Elevated urinary albumin excretion (UAE) is a predictor of the de

81 Twenty-four-hour urinary albumin excretion (UAE) is considered the gold s

82 The authors characterized urinary albumin excretion according to blood pressure, d

83 Here, we examined whether higher levels of urinary albumin excretion among African Americans contri

84 n in 13 type 1 diabetic subjects with normal urinary albumin excretion and 13 healthy volunteers.

85 brisentan attenuated the increases in BP and urinary albumin excretion and ameliorated endotheliosis

86 hat there is an association between elevated urinary albumin excretion and apolipoprotein B fraction

87 red the glomerular filtration rate (GFR) and urinary albumin excretion and assessed the prevalence of

88 ly overt manifestations, including increased urinary albumin excretion and decreased glomerular filtr

89 ssessed cross-sectional associations between urinary albumin excretion and dietary patterns and intak

90 iation was lost after further adjustment for urinary albumin excretion and eGFR [HR:1.15 (95% CI, 0.8

91 the frequency of a significant reduction in urinary albumin excretion and factors affecting such red

92 treatment with CTLA4-Ig prevented increased urinary albumin excretion and improved kidney pathology

93 /-1.2 vs 7.9+/-0.6 micromol/L p<0.01), while urinary albumin excretion and mesangial expansion were r

94 delay the onset and progression of increased urinary albumin excretion and reduced GFR in patients wi

95 We examined the association between urinary albumin excretion and the risks of hypertension

96 sion, extracellular matrix accumulation, and urinary albumin excretion as well as NOX4 protein expres

97 Urinary albumin excretion at 24 wk was also significantl

98 ted that treatment with sTbetaRII.Fc reduced urinary albumin excretion by 36% at 4 weeks, 59% at 8 we

99 ence is accumulating that early increases in urinary albumin excretion could be predictive of adolesc

100 ) with fasting lipids, apolipoprotein B, and urinary albumin excretion determined at baseline.

101 with type 1 diabetes indicates that elevated urinary albumin excretion does not imply inexorably prog

102 Decreased mGFR, metabolic syndrome, and urinary albumin excretion emerged as strong predictors o

103 Urinary albumin excretion exceeded 300 mg/d per 100 g bo

104 A risk of higher urinary albumin excretion exists at blood pressure level

105 ich was defined as a 50 percent reduction in urinary albumin excretion from one two-year period to th

106 Olmesartan attenuated urinary albumin excretion in adenine mice, but did not a

107 d statistical significance with variation in urinary albumin excretion in family members with type 2

108 n and podocyte apoptosis that contributes to urinary albumin excretion in type 1 diabetes.

109 tive oxygen species generation and to reduce urinary albumin excretion in type 1 diabetes.

110 Calpain inhibition also attenuated urinary albumin excretion in ZDF rats.

111 Urinary albumin excretion is an important diagnostic and

112 The rate of urinary albumin excretion is an important risk factor fo

113 Excess urinary albumin excretion is more common in black than w

114 Urinary albumin excretion level worsened to proteinuria

115 uria may occur in diabetes and how increased urinary albumin excretion may be indicative of CV risk.

116 Elevated urinary albumin excretion may share common causal pathwa

117 in excretion (P=0.006), and higher base-line urinary albumin excretion predicted a decline in the glo

118 Urinary albumin excretion predicts blood pressure progre

119 Higher urinary albumin excretion predicts future cardiovascular

120 correlation between plasma PK levels and the urinary albumin excretion rate (AER) was also observed (

121 Glomerular filtration rate (GFR) and urinary albumin excretion rate (UAER) are used to diagno

122 mated glomerular filtration rate (eGFR), and urinary albumin excretion rate (UAER).

123 survival studies in NIDDM, microalbuminuria (urinary albumin excretion rate 20-200 microg/min) predic

124 The mean urinary albumin excretion rate after washout was 40% (95

125 se in the iohexol-based GFR per year and the urinary albumin excretion rate after washout.

126 to high-density lipoprotein cholesterol, and urinary albumin excretion rate and with the mean glycosy

127 Increased urinary albumin excretion rate is widely accepted as the

128 poproteins, glycosylated hemoglobin, and the urinary albumin excretion rate were measured in a centra

129 t smoking, preexisting CHD, and high initial urinary albumin excretion rate were risk factors for the

130 dex, higher von Willebrand factor levels and urinary albumin excretion rate, hypertension, and smokin

131 and proximal tubule (PT) reclamation affect urinary albumin excretion rate.

132 Whether urinary albumin excretion relates to higher levels of at

133 gher in type 1 diabetic subjects with normal urinary albumin excretion than in control subjects.

134 Urinary albumin excretion values were higher in the obes

135 Percentage change in urinary albumin excretion was 5.7% (95% CI, -0.3% to 11.

136 -0.57 g per square meter per year, P<0.001); urinary albumin excretion was reduced by 3.77% with the

137 Such modification was also observed when urinary albumin excretion was stratified into normo-, mi

138 sive, nondiabetic individuals, low levels of urinary albumin excretion well below the current microal

139 rular capillary basement membrane width, and urinary albumin excretion were increased in diabetic rat

140 Histologic evidence of glomerular injury and urinary albumin excretion were more pronounced in double

141 Glomerular morphology and urinary albumin excretion were normal in Nmt mice.

142 We assessed the relationship of urinary albumin excretion with apolipoprotein B fraction

143 xplain, in part, the association of elevated urinary albumin excretion with cardiovascular disease ri

144 protein B fractions modified associations of urinary albumin excretion with incident cardiovascular d

145 termined whether the association of elevated urinary albumin excretion with incident cardiovascular e

146 LDO pod GC-A cKO mice demonstrated increased urinary albumin excretion with marked mesangial expansio

147 FR167653 also suppressed urinary albumin excretion without reducing SBP.

148 tid ultrasound, ankle-brachial pressure, and urinary albumin excretion) and stratified by body mass i

149 nal function (glomerular filtration rate and urinary albumin excretion), and routine biochemistry sho

150 Urinary albumin excretion, an index of renal damage, was

151 omerular filtration rate, renal plasma flow, urinary albumin excretion, and blood pressure were measu

152 lar filtration rate, serum creatinine level, urinary albumin excretion, and blood pressure; the rates

153 oponin-T, high-sensitive C-reactive protein, urinary albumin excretion, and cystatin-C had similar ri

154 ation of hypertension with serum creatinine, urinary albumin excretion, and ESRD in the United States

155 The rates of decline in the estimated GFR, urinary albumin excretion, and other secondary outcomes

156 imaging, we related arterial stiffness, GFR, urinary albumin excretion, and potential mediators, incl

157 In this study, the prevalence of urinary albumin excretion, determined in 308 Pima Indian

158 Whether incremental increases in urinary albumin excretion, even within the normal range,

159 At 2 mo, inulin clearance, urinary albumin excretion, fractional albumin clearance,

160 Urinary albumin excretion, fractional albumin clearance,

161 VC suppressed urinary albumin excretion, fractional albumin clearance,

162 betic Cav2.2(-/-) mice significantly reduced urinary albumin excretion, glomerular hyperfiltration, b

163 00 mg/kg body wt/d) in the drinking water on urinary albumin excretion, glomerular transforming growt

164 anced by lack of both B1R and B2R, including urinary albumin excretion, glomerulosclerosis, glomerula

165 -B-type natriuretic peptide, troponin-T, and urinary albumin excretion, increasing model accuracy to

166 m and long-term benefits of empagliflozin on urinary albumin excretion, irrespective of patients' alb

167 Urinary albumin excretion, mesangial expansion, glomerul

168 itor, reduced systolic blood pressure (SBP), urinary albumin excretion, segmental sclerosis, podocyte

169 ced glomerular filtration rate and increased urinary albumin excretion.

170 r adjustment for clinical covariates such as urinary albumin excretion.

171 thy controls, and positively correlated with urinary albumin excretion.

172 nce renal vascular integrity as reflected by urinary albumin excretion.

173 foot processes in the kidney glomerulus, and urinary albumin excretion.

174 trasound, ankle-brachial blood pressure, and urinary albumin excretion.

175 overlaps with genes controlling variation in urinary albumin excretion.

176 wed for 4 years with repeated assessments of urinary albumin excretion.

177 .89; p<0.0001), mainly due to a reduction in urinary albumin excretion.

178 edicts the impact of acute hyperglycaemia on urinary albumin excretion.

179 heat-induced skin hyperemic response; and as urinary albumin excretion.

180 erally is assessed by measurement of GFR and urinary albumin excretion.

181 ricular-mass index, and greater reduction in urinary albumin excretion.

182 inhibitor type 1), and microvascular damage (urinary albumin excretion; n=2673) to incident AF (n=209

183 An elevated urinary albumin-excretion rate is a known early predicto

184 bstantially attenuated, but the excretion of urinary albumin factored for creatinine clearance was no

185 s did not respond to nonrenal toxicants, and urinary albumin faithfully reflected alterations in rena

186 These results show that the generation of urinary albumin fragments occurs independently of renal

187 athophysiological implications of changes in urinary albumin fragments require reevaluation.

188 degradation of albumin forms the detectable urinary albumin fragments.

189 n reabsorbing, processing, and transcytosing urinary albumin from the glomerular filtrate.

190 e utility of measuring plasma creatinine and urinary albumin, has been almost entirely focused on the

191 Concomitant normal levels of urinary albumin, IgM and RBP identified normal histology

192 S have suggested that binding of diuretic to urinary albumin is one of the mechanisms that may be ope

193 Proteinuria (urinary albumin level and albumin/creatinine ratio) was

194 in diet significantly slowed the increase in urinary albumin level or the decline in glomerular filtr

195 emphasizes the difficulties in interpreting urinary albumin levels in early disease models.

196 Urinary albumin levels increased but reversed on discont

197 Urinary albumin levels increased, with tinnitus and atri

198 uclear factor-kappaB activity, and increased urinary albumin levels, all of which is similar to chang

199 ose and HbA1c levels, retinopathy, lipid and urinary albumin levels, cardiovascular events, hypoglyce

200 hose MPs in nondiabetic mice, despite normal urinary albumin levels.

201 It is unknown at what threshold of urinary albumin loss HDL structure is altered, and it is

202 r composite (3.8 vs 3.7, P = .93), or year 5 urinary albumin (median, 7.5 vs 7.4 mg/g of creatinine,

203 increased baseline systolic blood pressure, urinary albumin, plasma creatinine, and Indian-Asian eth

204 ea under the curve [AUC] 0.93) compared with urinary albumin routinely used to determine the diagnosi

205 Patients with glomerular lesions had higher urinary albumin than those with normal histology, while

206 s a critical mechanism for excessive loss of urinary albumin that eventuates in kidney fibrosis.

207 Albuminuria was defined as a ratio (mg/g) of urinary albumin to creatinine of >/=30.

208 g/dL; 95% CI, -0.7 to -0.07 mg/dL; P = .02), urinary albumin to creatinine ratio (-119.4 mg/g; 95% CI

209 The urinary albumin to creatinine ratio (ACR) assessed in a

210 Biomarkers included urinary IL-18, urinary albumin to creatinine ratio (ACR), and urinary a

211 he prevalence and prognostic value of a spot urinary albumin to creatinine ratio (UACR) in patients w

212 of baseline eGFR (<60 vs 60 mL/min/1.73 m2), urinary albumin to creatinine ratio (UACR; <30 vs 30 mg/

213 5 years with proteinuria (first morning void urinary albumin to creatinine ratio [UACR] 100-3000 mg/g

214 r, these mice showed a four-fold increase in urinary albumin to creatinine ratio and development of f

215 gression, on the basis of either eGFR or the urinary albumin to creatinine ratio, in MESA participant

216 ption and rate of eGFR decline or changes in urinary albumin to creatinine ratio.

217 +/- 1, mutant versus control), albuminuria (urinary albumin to creatinine ratio: 23 +/- 15 versus 0.

218 ities of urinary trefoil factor 3 (TFF3) and urinary albumin to detect acute renal tubular injury hav

219 In the subgroup of patients with baseline urinary albumin-to-creatinine ratio >/=30 mg/g, urinary

220 1.73 m(2) and macroalbuminuria defined by a urinary albumin-to-creatinine ratio >300 mg/g, were rand

221 tinine-based eGFR<60 ml/min per 1.73 m(2) or urinary albumin-to-creatinine ratio >=30 mg/g.

222 th diabetes duration >20 years and a maximum urinary albumin-to-creatinine ratio <150 mg/g.

223 er 1 SD increment in the log values) and the urinary albumin-to-creatinine ratio (1.20).

224 (1.40), C-reactive protein level (1.39), the urinary albumin-to-creatinine ratio (1.22), homocysteine

225 ifferences in Stroke (REGARDS) study who had urinary albumin-to-creatinine ratio (ACR) and estimated

226 L/min/1.73 m2, 15% had diabetes and 8.4% had urinary albumin-to-creatinine ratio (ACR) available (med

227 lar filtration rate (eGFR(cys)) and measured urinary albumin-to-creatinine ratio (ACR) in 10 328 men

228 We examined race-stratified associations of urinary albumin-to-creatinine ratio (ACR) in 2 groups: (

229 Urinary albumin-to-creatinine ratio (ACR) is a marker of

230 ing pairs, as well as the quantitative trait urinary albumin-to-creatinine ratio (ACR), were performe

231 imated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR), with cancer i

232 al of 1,269 subjects had UAE measured as the urinary albumin-to-creatinine ratio (ACR).

233 diet (food-frequency questionnaire) and the urinary albumin-to-creatinine ratio (ACR; spot urine col

234 Urinary albumin-to-creatinine ratio (albuminuria) was ca

235 genetic underpinnings with the exception of urinary albumin-to-creatinine ratio (Rg = 0.64; SE = 0.2

236 s were adult patients with CKD, defined as a urinary albumin-to-creatinine ratio (UACR) 200-5000 mg/g

237 GFR-associated SNPs for association with the urinary albumin-to-creatinine ratio (UACR) and albuminur

238 icoid receptor antagonists (MRAs) reduce the urinary albumin-to-creatinine ratio (UACR) and confer ki

239 mplitude, while nephropathy was evaluated by urinary albumin-to-creatinine ratio (UACR) and eGFR.

240 Increased levels of the urinary albumin-to-creatinine ratio (UACR) are associate

241 Here, we report urinary albumin-to-creatinine ratio (UACR) data for the

242 In type 1 diabetes, increased urinary albumin-to-creatinine ratio (uACR) during adoles

243 nuous positive airway pressure (CPAP) on the urinary albumin-to-creatinine ratio (UACR) in patients w

244 cts with eGFR >20 ml/min per 1.73 m(2) and a urinary albumin-to-creatinine ratio (UACR) of 100 to 300

245 of 20 mL/min per 1.73 m(2) or greater and a urinary albumin-to-creatinine ratio (UACR) of 150-5000 m

246 age estimated glomerular filtration rate and urinary albumin-to-creatinine ratio (uACR) over 3 months

247 variants in CUBN, encoding cubilin, with the urinary albumin-to-creatinine ratio (UACR) were confirme

248 t, Trf1(Delta/Delta) mice displayed elevated urinary albumin-to-creatinine ratio (UACR), associated w

249 per day) to patients with type 2 diabetes, a urinary albumin-to-creatinine ratio (with albumin measur

250 s than 90 ml per minute per 1.73 m(2) with a urinary albumin-to-creatinine ratio (with albumin measur

251 Eligible patients had a urinary albumin-to-creatinine ratio (with albumin measur

252 Eligible patients had a urinary albumin-to-creatinine ratio (with albumin measur

253 ration rate (eGFR) 25-75 mL/min/1.73m(2) and urinary albumin-to-creatinine ratio 200-5000 mg/g (22.6-

254 Adults with CKD (urinary albumin-to-creatinine ratio 200-5000 mg/g and es

255 es, with eGFR 25-75 ml/min per 1.73 m(2) and urinary albumin-to-creatinine ratio 200-5000 mg/g were r

256 ular filtration rate 25-75 ml/min/1.73 m(2); urinary albumin-to-creatinine ratio 300-5000 mg/g).

257 tion rate [eGFR] of 30-90 mL/min/1.73 m2 and urinary albumin-to-creatinine ratio [UACR] of 200-5000 m

258 r more and under 90 mL/min per 1.73 m(2) and urinary albumin-to-creatinine ratio [UACR] over 50 mg/g)

259 ral pulse wave velocity associated with both urinary albumin-to-creatinine ratio and microalbuminuria

260 tion was stratified on the basis of baseline urinary albumin-to-creatinine ratio and presence of card

261 rular barrier dysfunction assessed using the urinary albumin-to-creatinine ratio and urinary ratio of

262 we identified B-type natriuretic peptide and urinary albumin-to-creatinine ratio as key risk factors

263 Dapagliflozin reduced the urinary albumin-to-creatinine ratio by 26% relative to p

264 nary albumin-to-creatinine ratio >/=30 mg/g, urinary albumin-to-creatinine ratio decreased more with

265 elimination, B-type natriuretic peptide and urinary albumin-to-creatinine ratio emerged as key bioma

266 Loci suggestive for linkage to urinary albumin-to-creatinine ratio included 1q, 6p, 9q,

267 Estimated GFR, blood pressure, and the urinary albumin-to-creatinine ratio increased significan

268 Elevated urinary albumin-to-creatinine ratio is a measure of kidn

269 ior), we observed a significant reduction in urinary albumin-to-creatinine ratio of 15.7% (ratio 0.84

270 r filtration rate 15-59 ml/min/1.73m(2) or a urinary albumin-to-creatinine ratio of 30 mg/g or more)

271 rea, and diabetic retinopathy, or they had a urinary albumin-to-creatinine ratio of 300 to 5000 and a

272 of body-surface area (stage 2 to 4 CKD) or a urinary albumin-to-creatinine ratio of 300 to 5000 and a

273 B-type natriuretic peptide and urinary albumin-to-creatinine ratio significantly improv

274 agliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either treatmen

275 (25-47) ml/min per 1.73 m(2), and the median urinary albumin-to-creatinine ratio was 197 (32-895) mg/

276 s 52.9 (29.3) mL/min/1.73 m2, and the median urinary albumin-to-creatinine ratio was 89 mg/g (coeffic

277 Urinary albumin-to-creatinine ratio was calculated in mi

278 respectively) and the mean reduction in the urinary albumin-to-creatinine ratio was greater (between

279 At baseline, the urinary albumin-to-creatinine ratio was similar among th

280 lobin A1c levels, creatinine levels, and the urinary albumin-to-creatinine ratio were recorded.

281 At day 180, the reduction in the urinary albumin-to-creatinine ratio with combination the

282 emonstrate that dh404 attenuates functional (urinary albumin-to-creatinine ratio) and structural (mes

283 renin ratio, B-type natriuretic peptide, and urinary albumin-to-creatinine ratio).

284 mean eGFR, 43.8 mL/min/1.73m(2); and median urinary albumin-to-creatinine ratio, 900 mg/g.

285 ohort (R=-0.52 for estimated GFR, R=0.22 for urinary albumin-to-creatinine ratio, and R=0.17 for urin

286 of follow-up, after adjustment for baseline urinary albumin-to-creatinine ratio, eGFR, and Hb1Ac.

287 the change from baseline to 12 weeks in the urinary albumin-to-creatinine ratio, N-terminal pro-B-ty

288 d blood glucose, glomerular filtration rate, urinary albumin-to-creatinine ratio, tubulointerstitial

289 calize gene regions influencing variation in urinary albumin-to-creatinine ratio, we performed a link

290 aseline and longitudinal changes in eGFR and urinary albumin-to-creatinine ratio.

291 inhibitor type 1, and homocysteine; and the urinary albumin-to-creatinine ratio.

292 e protein, sST2, galectin-3, cystatin-C, and urinary albumin-to-creatinine ratio.

293 aortic pulsed wave velocity, cystatin C, and urinary albumin-to-creatinine ratio.

294 wave velocity by magnetic resonance imaging; urinary albumin-to-creatinine ratio; and cystatin C were

295 risk factors (age, sex, ethnicity, eGFR, and urinary albumin-to-creatinine ratio; C-index, 0.90; 95%

296 Urinary albumin-to-creatinine ratios (UACRs) and estimat

297 rasentan (7.5 mg/kg/day) for 4 weeks reduced urinary albumin-to-creatinine ratios by 26.0 +/- 6.5% (P

298 and immune cell activation and response for urinary albumin-to-creatinineratio-associated CpGs.

299 n, the more Lambeta1 was expressed, the less urinary albumin was excreted.

300 F3 protein levels were markedly reduced, and urinary albumin were markedly increased in response to r